Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raed Alroughani

Showing results (11-20 of 223) with videos related to

Pageof 23
Sort By:
BMC Neurology|February 23, 2020
A matched case-control study of risk factors associated with multiple sclerosis in KuwaitHadeel El-Muzaini, Saeed Akhtar, Raed Alroughani
Experimental and Molecular Pathology|May 21, 2024
Analysis of potential microRNA biomarkers for multiple sclerosisRabeah Al-Temaimi, Nashmeiah Alshammari, Raed Alroughani
BMC Neurology|September 25, 2020
Correction to: A matched case-control study of risk factors associated with multiple sclerosis in KuwaitHadeel El-Muzaini, Saeed Akhtar, Raed Alroughani
Neurology International|October 22, 2015
Yet Another Atypical Presentation of Anti-GQ1b Antibody SyndromeRaed Alroughani, Anil Thussu, Raouf T Guindi
Neuroepidemiology|November 17, 2025
The Role of Dietary and Lifestyle Factors in Multiple Sclerosis Risk in a Middle Eastern Country: A Case-Control StudyReem Nawaf Aqel, Saeed Akhtar, Raed Alroughani
Clinical Neurology and Neurosurgery|March 21, 2024
Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
BMC Neurology|July 5, 2023
Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental studySaeed Akhtar, Jasem Y Al-Hashel, Raed Alroughani
Multiple Sclerosis and Related Disorders|February 2, 2025
Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Annals of Saudi Medicine|October 1, 2014
A young male presented with acute inguinal pain, bilateral quadriceps weakness and hyperesthesia of anterior thighs post-thrombolysis for acute myocardial infarctionShekhar Lamdhade, Raja Dashti, Anil Thussu, et al.
Pediatric Neurology|September 19, 2015
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective AnalysisRaed Alroughani, Samar F Ahmed, Jasem Al-Hashel
Pageof 23

Showing results (11-20 of 223) with videos related to

Sort By:
Pageof 23
BMC Neurology|February 23, 2020
A matched case-control study of risk factors associated with multiple sclerosis in KuwaitHadeel El-Muzaini, Saeed Akhtar, Raed Alroughani
Experimental and Molecular Pathology|May 21, 2024
Analysis of potential microRNA biomarkers for multiple sclerosisRabeah Al-Temaimi, Nashmeiah Alshammari, Raed Alroughani
BMC Neurology|September 25, 2020
Correction to: A matched case-control study of risk factors associated with multiple sclerosis in KuwaitHadeel El-Muzaini, Saeed Akhtar, Raed Alroughani
Neurology International|October 22, 2015
Yet Another Atypical Presentation of Anti-GQ1b Antibody SyndromeRaed Alroughani, Anil Thussu, Raouf T Guindi
Neuroepidemiology|November 17, 2025
The Role of Dietary and Lifestyle Factors in Multiple Sclerosis Risk in a Middle Eastern Country: A Case-Control StudyReem Nawaf Aqel, Saeed Akhtar, Raed Alroughani
Clinical Neurology and Neurosurgery|March 21, 2024
Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
BMC Neurology|July 5, 2023
Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental studySaeed Akhtar, Jasem Y Al-Hashel, Raed Alroughani
Multiple Sclerosis and Related Disorders|February 2, 2025
Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Annals of Saudi Medicine|October 1, 2014
A young male presented with acute inguinal pain, bilateral quadriceps weakness and hyperesthesia of anterior thighs post-thrombolysis for acute myocardial infarctionShekhar Lamdhade, Raja Dashti, Anil Thussu, et al.
Pediatric Neurology|September 19, 2015
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective AnalysisRaed Alroughani, Samar F Ahmed, Jasem Al-Hashel
Pageof 23